Do you have the same question? Follow this Question
Jan 22, 2026 - 01:01 PM
We’ve provided several answers to questions related to Synjardy XR (Empagliflozin / Metformin HCI) , see some other helpful Q&A related to this product.
Question: Is this medication approved by the FDA?
Answer: Yes, this medication is approved by the FDA (U.S. Food and Drug Administration) and other regulatory bodies for the treatment of type 2 diabetes. FDA approval indicates that the medication has been thoroughly evaluated for safety and effectiveness.
Question: What are the active ingredients in each tablet?
Answer: Each tablet contains empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin hydrochloride, a biguanide. SGLT2 inhibitors help remove excess sugar through urine, and biguanides help lower blood sugar by decreasing glucose production in the liver.
Question: What is the route of administration?
Answer: The medication is taken by mouth. Oral tablets provide a convenient and non-invasive way to manage diabetes, making adherence to treatment easier for most adults.
View all Synjardy XR (Empagliflozin / Metformin HCI) Questions & Answers
